OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular and cellular basis of the anticancer activity of the prenylated flavonoid icaritin in hepatocellular carcinoma
Christian Bailly
Chemico-Biological Interactions (2020) Vol. 325, pp. 109124-109124
Closed Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Important Flavonoids and Their Role as a Therapeutic Agent
Asad Ullah, Sidra Munir, Syed Lal Badshah, et al.
Molecules (2020) Vol. 25, Iss. 22, pp. 5243-5243
Open Access | Times Cited: 985

Treatment for liver cancer: From sorafenib to natural products
Shuli Man, Chen Luo, Mengyao Yan, et al.
European Journal of Medicinal Chemistry (2021) Vol. 224, pp. 113690-113690
Closed Access | Times Cited: 134

Anti-inflammatory and immunoregulatory effects of icariin and icaritin
Zhangyang Bi, Wei Zhang, Xiaoyan Yan
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113180-113180
Open Access | Times Cited: 114

Progress in approved drugs from natural product resources
Zhongwen Luo, Fucheng Yin, Xiaobing Wang, et al.
Chinese Journal of Natural Medicines (2024) Vol. 22, Iss. 3, pp. 195-211
Closed Access | Times Cited: 77

Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles
Alena Líšková, Marek Samec, Lenka Koklesová, et al.
The EPMA Journal (2021) Vol. 12, Iss. 2, pp. 155-176
Open Access | Times Cited: 98

The Potential Role of Flavonoids in Ameliorating Diabetic Cardiomyopathy via Alleviation of Cardiac Oxidative Stress, Inflammation and Apoptosis
Fatin Farhana Jubaidi, Satirah Zainalabidin, Izatus Shima Taib, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5094-5094
Open Access | Times Cited: 81

Current methodologies to refine bioavailability, delivery, and therapeutic efficacy of plant flavonoids in cancer treatment
Cijo George Vazhappilly, Madumani Amararathna, Asha Caroline Cyril, et al.
The Journal of Nutritional Biochemistry (2021) Vol. 94, pp. 108623-108623
Closed Access | Times Cited: 55

Flavonoids regulate tumor-associated macrophages – From structure-activity relationship to clinical potential (Review)
Qi Sun, Qi Liu, Xintong Zhou, et al.
Pharmacological Research (2022) Vol. 184, pp. 106419-106419
Closed Access | Times Cited: 51

Estrogenic flavonoids and their molecular mechanisms of action
Ryoiti Kiyama
The Journal of Nutritional Biochemistry (2022) Vol. 114, pp. 109250-109250
Open Access | Times Cited: 44

Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
Yifan Xie, Feng Xie, Lei Zhang, et al.
Advanced Science (2021) Vol. 8, Iss. 22
Open Access | Times Cited: 52

Review of the Applications of Biomedical Compositions Containing Hydroxyapatite and Collagen Modified by Bioactive Components
Agnieszka Sobczak‐Kupiec, Anna Drabczyk, Wioletta Florkiewicz, et al.
Materials (2021) Vol. 14, Iss. 9, pp. 2096-2096
Open Access | Times Cited: 49

Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy
Juwon Lee, Youngjin Han, Wenyu Wang, et al.
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1107-1107
Open Access | Times Cited: 45

Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
Yi Lu, Yue Gao, Huan Yang, et al.
Military Medical Research (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 34

Anticancer Potential of Natural Chalcones: In Vitro and In Vivo Evidence
Radka Michalková, Ladislav Mirossay, Martin Kello, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10354-10354
Open Access | Times Cited: 18

De novo biosynthesis of anticarcinogenic icariin in engineered yeast
Ting An, Guangyuan Lin, Yang Liu, et al.
Metabolic Engineering (2023) Vol. 80, pp. 207-215
Closed Access | Times Cited: 18

Flavonoids as Strong Inhibitors of MAPK3: A Computational Drug Discovery Approach
Amir Taherkhani, Parita Khodadadi, Lida Samie, et al.
International Journal of Analytical Chemistry (2023) Vol. 2023, pp. 1-16
Open Access | Times Cited: 17

Sex Disparity in Cancer: Role of Autophagy and Estrogen Receptors
Rosa Vona, Camilla Cittadini, Elena Ortona, et al.
Cells (2025) Vol. 14, Iss. 4, pp. 273-273
Open Access

Icaritin inhibits PD‐L1 expression by Targeting Protein IκB Kinase α
Dongliang Mo, Hai Zhu, Jun Wang, et al.
European Journal of Immunology (2020) Vol. 51, Iss. 4, pp. 978-988
Open Access | Times Cited: 47

Flavonoids as promising anticancer therapeutics: Contemporary research, nanoantioxidant potential, and future scope
Mukta Gupta, Javed Ahmad, Javed Ahamad, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 11, pp. 5159-5192
Closed Access | Times Cited: 13

New insights into the anticancer therapeutic potential of icaritin and its synthetic derivatives
Octavio D. Reyes‐Hernández, Gabriela Figueroa‐González, Laura Itzel Quintas‐Granados, et al.
Drug Development Research (2024) Vol. 85, Iss. 2
Closed Access | Times Cited: 4

Flavonoids-Rich Plant Extracts Against Helicobacter pylori Infection as Prevention to Gastric Cancer
Renaly Ivyna de Araújo Rêgo, Geovana Ferreira Guedes Silvestre, Demis Ferreira de Melo, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 18

Icariin as a potential anticancer agent: a review of its biological effects on various cancers
Fang-Yuan Liu, Dan‐Ni Ding, Yun-Rui Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11

Page 1 - Next Page

Scroll to top